All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
AZN real return snapshot: after CPI-U inflation, AZN returned −2.09% over the past year and −12.91% YTD, with dividends reinvested. Since May 12, 1993, AZN is up +2,182.60% in real purchasing-power return, or +9.84%/yr, and is currently −23.36% below its real total-return high on Feb. 27, 2026.
Data ending Fri Sep. 4, 2026
| Wed 1993-05-12💬 to Fri 2026-09-04 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| AZN × |
+2,182.60%
+9.84%/yr |
+7.91%/yr
R2=0.891 |
||||
| AstraZeneca PLC NYSE Common Stock | ||||||
| Wed 1993-05-12💬 to Fri 2026-09-04 |
Start
Value |
End
Value |
|---|---|---|
| AZN × |
$10,000.00
1993-05-12 |
$228,259.56
2026-09-04 |
| YTD | YoY | |
|---|---|---|
| AZN × | −12.91% | −2.09% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| AZN × |
−23.36%
on 2026-09-04 from 2026-02-27 peak |
−51.42%
on 2009-03-09 from 2006-10-25 peak |
| Period ending Fri 2026-09-04 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| AZN × | −2.09% |
−7.35% −3.74%/yr |
+16.16% +5.12%/yr |
+25.35% +4.62%/yr |
+132.30% +8.79%/yr |
| Year | AZN |
|---|---|
| 2026 (YTD) | −12.91% |
| 2025 | +39.57% |
| 2024 | −3.40% |
| 2023 | −1.85% |
| 2022 | +11.92% |
| 2021 | +11.86% |
| 2020 | +1.74% |
| 2019 | +32.65% |
| 2018 | +11.73% |
| 2017 | +30.48% |
| 2016 | −14.57% |
| 2015 | +4.61% |
| 2014 | +22.63% |
| 2013 | +31.20% |
| 2012 | +6.66% |
| 2011 | +2.99% |
| 2010 | +1.99% |
| 2009 | +17.16% |
| 2008 | +0.08% |
| 2007 | −20.72% |
| 2006 | +10.52% |
| 2005 | +32.37% |
| 2004 | −25.86% |
| 2003 | +38.23% |
| 2002 | −25.02% |
| 2001 | −9.31% |
| 2000 | +24.46% |
| 1999 | −8.13% |
| 1998 | +25.00% |
| 1997 | +29.54% |
| 1996 | +42.33% |
| 1995 | +43.65% |
| 1994 | +12.32% |
| 1993 | +23.87% |
